Tan-Indo Pharma Private Limited
About Tan-Indo Pharma Private Limited
Data last updated:
Tan-Indo Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Cisb Services Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2019PTC320012. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Krishna Narsingrao Pimple and Sidhant Krishna Pimple.
Its last annual general meeting (AGM) was held on 28 August 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 101 Kushwah Chambers Makwana Road Opp Apurva Industrial Estate Marol, Mumbai, Maharashtra, India – 400059.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Tan-Indo Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address101 Kushwah Chambers Makwana Road Opp Apurva Industrial Estate Marol, Mumbai, Maharashtra, India – 400059
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Tan-Indo Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Tan-Indo Pharma Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Tan-Indo Pharma Private Limited, buy the company report.
Board of directors of Tan-Indo Pharma Private Limited
Tan-Indo Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Krishna Narsingrao Pimple | Director | 22 Jan 2019 | 7 Years 9 Months | Current |
| Sidhant Krishna Pimple Also directs: Atlantic Bloomfield LLP, Azzura Atlantic LLP, Cisb Management Services Private Limited and 1 more | Director | 22 Aug 2024 | 2 Years 2 Months | Current |
Auditor
Tan-Indo Pharma Private Limited is audited by PRASHANT MITTAL & CO. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRASHANT MITTAL & CO. LLP | FY 2023 | 135781W/W100111 |
Shareholding
The shareholding of Tan-Indo Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Tan-Indo Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Tan-Indo Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tan-Indo Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Tan-Indo Pharma has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
GST
Tan-Indo Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Tan-Indo Pharma Private Limited, buy the company report.
Recent activity
Tan-Indo Pharma Private Limited has 3 board changes on record since 2019: 2 appointments and 1 cessation. The latest: Siddarth Jambukumar Jain ceased to be Director on 22 Aug 2024.
Frequently asked questions
Tan-Indo Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 January 2019 (7+ years old) and is registered under CIN U74999MH2019PTC320012.
Tan-Indo Pharma has 2 current directors:
- Krishna Narsingrao Pimple - Director
- Sidhant Krishna Pimple - Director
The latest financial statements of Tan-Indo Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 28 August 2025. Year-wise statements from FY 2019 are in the company report.
No. Tan-Indo Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Tan-Indo Pharma is U74999MH2019PTC320012. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Tan-Indo Pharma was incorporated on 22 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
Siddarth Jambukumar Jain ceased to be Director on 22 Aug 2024. Sidhant Krishna Pimple was appointed as Director on 22 Aug 2024. Krishna Narsingrao Pimple was appointed as Director on 22 Jan 2019.
The registered office of Tan-Indo Pharma is at 101 Kushwah Chambers Makwana Road Opp Apurva Industrial Estate Marol, Mumbai, Maharashtra, India – 400059.
Tan-Indo Pharma operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Tan-Indo Pharma is compliant as of 03 August 2026. The company is actively filing with the Registrar of Companies.